On basis of these recently published mechanistic findings, our in vitro results indicate that CFHR5 regulation of the alternative pathway of complement activation has a role in C3a mediated platelet activation in thrombosis, providing a potential functional link to its association with acute VTE. This evidence concerns the gene CFHR5 and deep vein thrombosis.